NXGL NEXGEL, INC.

Nasdaq nexgel.com


$ 2.23 $ -0.15 (-6.38 %)    

Tuesday, 04-Nov-2025 15:59:54 EST
QQQ $ 617.45 $ -12.83 (-2.03 %)
DIA $ 471.47 $ -2.57 (-0.54 %)
SPY $ 674.40 $ -8.10 (-1.19 %)
TLT $ 89.95 $ 0.20 (0.22 %)
GLD $ 361.76 $ -6.46 (-1.75 %)
$ 2.2001
$ 2.34
$ 2.20 x 7
$ 2.30 x 40
$ 2.20 - $ 2.38
$ 2.10 - $ 5.10
86,695
na
17.75M
$ 0.53
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-12-2025 06-30-2025 10-Q
2 05-13-2025 03-31-2025 10-Q
3 03-27-2025 12-31-2024 10-K
4 11-13-2024 09-30-2024 10-Q
5 08-19-2024 06-30-2024 10-Q
6 05-13-2024 03-31-2024 10-Q
7 04-10-2024 12-31-2023 10-K
8 11-13-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 03-28-2023 12-31-2022 10-K
12 11-08-2022 09-30-2022 10-Q
13 08-10-2022 06-30-2022 10-Q
14 05-13-2022 03-31-2022 10-Q
15 03-21-2022 12-31-2021 10-K
16 11-10-2021 09-30-2021 10-Q
17 08-16-2021 06-30-2021 10-Q
18 05-17-2021 03-31-2021 10-Q
19 03-31-2021 12-31-2020 10-K
20 11-16-2020 09-30-2020 10-Q
21 08-14-2020 06-30-2020 10-Q
22 05-14-2020 03-31-2020 10-Q
23 03-30-2020 12-31-2019 10-K
24 01-28-2020 09-30-2019 10-Q
25 09-09-2019 06-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 correction-nexgel-q2-eps-009-misses-007-estimate-sales-2884m-miss-3080m-estimate

NexGel (NASDAQ:NXGL) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.07) by 2...

 an-overview-of-nexgels-earnings
An Overview of NexGel's Earnings
08/11/2025 19:04:35

 nexgel-expands-partnership-with-stada-to-launch-new-digestive-and-skin-care-products-receives-1m-non-dilutive-funding

NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a leading provider of ultra-gentle, high-wat...

 nexgel-q1-eps-009-beats-010-estimate-sales-281m-beat-273m-estimate

NexGel (NASDAQ:NXGL) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.10) by 10 ...

 nexgel-expects-q4-2024-revenue-at-3m-fy24-total-revenue-86m-predicts-13m-revenue-for-2025-cash-flow-positive-highlights-growth-in-contract-manufacturing-consumer-products

Management expects 2024 fourth quarter revenue of approximately $3.0 million and full year 2024 of approximately $8.6 million, ...

 nexgel-q3-eps-011-misses-010-estimate-sales-294m-beat-285m-estimate

NexGel (NASDAQ:NXGL) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.10) by 1...

 nexgel-preliminary-revenue-for-q3-2024-of-285m-an-increase-of-133-yoy-as-well-as-an-increase-of-30-over-the-companys-previously-issued-july-q3-revenue-guidance-of-220m

NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a leading provider of medical and over-the-c...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION